PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426V906. A total of 2 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | – | 293 | +29200.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | -75.0% | 0.00% | – |
| Q1 2018 | $0 | – | 4 | -85.7% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 28 | +27.3% | 0.00% | – |
| Q3 2017 | $2,000 | -71.4% | 22 | -89.5% | 0.00% | – |
| Q2 2017 | $7,000 | +600.0% | 209 | +364.4% | 0.00% | – |
| Q1 2017 | $1,000 | – | 45 | +18.4% | 0.00% | – |
| Q4 2016 | $0 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 1 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |